Lantheus Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Aug 1, 2017 and accepted by EDGAR at Aug 1, 2017, 17:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 3 months2017-03-31 to 2017-06-30 | $45.9m | us-gaap:GrossProfit |
| Gross profit | 6 months2017-01-01 to 2017-06-30 | $85.7m | us-gaap:GrossProfit |
| Research and development | 3 months2017-03-31 to 2017-06-30 | $5.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2017-01-01 to 2017-06-30 | $10.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2017-03-31 to 2017-06-30 | $17.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | $29.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-03-31 to 2017-06-30 | $4.3m | us-gaap:InterestExpense |
| Interest expense | 6 months2017-01-01 to 2017-06-30 | $9.7m | us-gaap:InterestExpense |
| Income tax | 3 months2017-03-31 to 2017-06-30 | $569.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | $1.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months2017-01-01 to 2017-06-30 | $17.7m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months2017-03-31 to 2017-06-30 | $0.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | $0.46 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-03-31 to 2017-06-30 | $0.37 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | $0.48 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-03-31 to 2017-06-30 | 38,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 38,726,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $8.3m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2017-06-30 | $57.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $125.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $267.9m | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $43.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-06-30 | $355.1m | us-gaap:Liabilities |
| Long-term debt | At period end2017-06-30 | $265.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-06-30 | $2.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-06-30 | −$87.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-17-244385. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.